← Back to Clinical Trials
Recruiting NCT05178966

NCT05178966 Evaluation of Efficiency of One Day Patient/Caregiver Psychoeducation on the Caregiver's Burden

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05178966
Status Recruiting
Phase
Sponsor University Hospital, Montpellier
Condition Bipolar Disorder
Study Type INTERVENTIONAL
Enrollment 240 participants
Start Date 2022-11-09
Primary Completion 2025-11-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Bp OneDay psychoeducation program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 240 participants in total. It began in 2022-11-09 with a primary completion date of 2025-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Bipolar disorder (BD) has a huge impact on the lives of patient and their relatives. Psychoeducation programs on BD has been shown to be effective on the burden of patients and their caregivers. However, actual programs appear to be incompatible with patients obligations and services requirements of the service. The development of "minute" programs (in one day) is justified.

Eligibility Criteria

Patient inclusion Criteria: * Be over 18 years old; * Meet the criteria for bipolar disorder (I, II, unspecified) according to the DSM-5 criteria; * Be able to understand the nature, purpose and methodology of the study; * Presence of a caregiver Patient Exclusion Criteria: * Subject unable to adhere to the group requirements (cognitive disorder, decompensated mood state ...); * Subject protected by law (subject under guardianship and / or guardianship) or deprived of liberty by a judicial or administrative decision; * Subject unable to understand, speak and write French; * Subject in a period of exclusion from another protocol. * Subject not having signed an informed consent * Subject not affiliated with a social security scheme or such a scheme Caregiver inclusion criteria ; * Subject over 18 years old; * Subject designated as a regular caregiver of a patient with bipolar disorder. A regular caregiver is a trusted person designated by the patient as being one of his main support, having knowledge of the diagnosis of bipolar disorder and who can be called upon in the context of care. * Subject able to understand the nature, purpose and methodology of the study; Caregiver exclusion criteria : * Subject unable to adhere to the groupre quirements (cognitive disorder, decompensated mood state ...); * Subject protected by law (subject under guardianship and / or curatorship) or deprived of liberty by a judicial or administrative decision ; * Subject unable to understand, speak and write French; * Subject in a period of exclusion from another protocol. * Subject not having signed an informed consent * Subject not affiliated with a social security scheme or such a scheme

Contact & Investigator

Central Contact

Kathlyne DUPUIS MAURIN

✉ k-dupuis@chu-montpellier.fr

📞 +33467335663

Frequently Asked Questions

Who can join the NCT05178966 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Bipolar Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05178966 currently recruiting?

Yes, NCT05178966 is actively recruiting participants. Contact the research team at k-dupuis@chu-montpellier.fr for enrollment information.

Where is the NCT05178966 trial being conducted?

This trial is being conducted at Montpellier, France.

Who is sponsoring the NCT05178966 clinical trial?

NCT05178966 is sponsored by University Hospital, Montpellier. The trial plans to enroll 240 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology